Shenzhen Glory Medical Co.,Ltd.

SZSE:002551 Stock Report

Market Cap: CN¥3.0b

Shenzhen Glory MedicalLtd Past Earnings Performance

Past criteria checks 0/6

Shenzhen Glory MedicalLtd's earnings have been declining at an average annual rate of -57.9%, while the Construction industry saw earnings growing at 6.6% annually. Revenues have been declining at an average rate of 9.5% per year.

Key information

-57.9%

Earnings growth rate

-59.1%

EPS growth rate

Construction Industry Growth8.6%
Revenue growth rate-9.5%
Return on equity-5.8%
Net Margin-11.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Optimistic Investors Push Shenzhen Glory Medical Co.,Ltd. (SZSE:002551) Shares Up 38% But Growth Is Lacking

Oct 08
Optimistic Investors Push Shenzhen Glory Medical Co.,Ltd. (SZSE:002551) Shares Up 38% But Growth Is Lacking

Risks Still Elevated At These Prices As Shenzhen Glory Medical Co.,Ltd. (SZSE:002551) Shares Dive 29%

Jun 06
Risks Still Elevated At These Prices As Shenzhen Glory Medical Co.,Ltd. (SZSE:002551) Shares Dive 29%

Revenues Not Telling The Story For Shenzhen Glory Medical Co.,Ltd. (SZSE:002551) After Shares Rise 28%

Mar 08
Revenues Not Telling The Story For Shenzhen Glory Medical Co.,Ltd. (SZSE:002551) After Shares Rise 28%

Revenue & Expenses Breakdown

How Shenzhen Glory MedicalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002551 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,277-14822739
30 Jun 241,224-14621939
31 Mar 241,160-14221740
31 Dec 231,193-14923140
30 Sep 231,254-25026545
30 Jun 231,248-25227246
31 Mar 231,101-31131543
01 Jan 231,276-30830948
30 Sep 221,578-7616549
30 Jun 221,546-7517849
31 Mar 221,725313049
01 Jan 221,7904517752
30 Sep 211,87411023655
30 Jun 212,17314322359
31 Mar 212,45817327863
31 Dec 202,26716221461
30 Sep 201,91813023053
30 Jun 201,7029923850
31 Mar 201,5377020446
01 Jan 201,5316021648
30 Sep 191,4415324845
30 Jun 191,3545619750
31 Mar 191,4837322540
01 Jan 191,6309822346
30 Sep 181,84113318458
30 Jun 182,06217618672
31 Mar 181,90917717067
31 Dec 172,00617518351
30 Sep 172,09312925533
30 Jun 172,1121262670
31 Mar 172,0381202840
31 Dec 161,9461142810
30 Sep 161,9241322380
30 Jun 161,6501332730
31 Mar 161,8701312370
31 Dec 151,6661192370
30 Sep 151,4501332230
30 Jun 151,5471201980
31 Mar 151,2341111980
31 Dec 141,1671021840
30 Sep 141,143961780
30 Jun 14929861600
31 Mar 14815801420
31 Dec 13731741300

Quality Earnings: 002551 is currently unprofitable.

Growing Profit Margin: 002551 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002551 is unprofitable, and losses have increased over the past 5 years at a rate of 57.9% per year.

Accelerating Growth: Unable to compare 002551's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 002551 is unprofitable, making it difficult to compare its past year earnings growth to the Construction industry (-3.9%).


Return on Equity

High ROE: 002551 has a negative Return on Equity (-5.84%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 06:55
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen Glory Medical Co.,Ltd. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wayne HeChina Stock Investment Research Co. Ltd. (GZ500..com)
Weina JiangEverbright Securities Co. Ltd.
Lin ZhangGreat Wall Securities Co., Ltd.